Dr Reddys Laboratories ADR repsg 1 Ord Shs C.RDY

Primary Symbol: RDY

Healthcare

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).

NYSE:RDY - Post by User

Dr Reddys Laboratories ADR repsg 1 Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by 10malsoonon Sep 10, 2021 5:50am

224 Views

Post# 33838632

AGM

Has anyone received Information for AGM on Oct. 12th. CBLT, RDY, and Concept Capital the big Shareholders. If Concept Capital Exercises their shares from the Financing then they will Call the Shots for the New Boatd. This would likely be the best Outcome for current Shareholders. If they don't, than CBLT will most likely take control of the board. Status Quo from current board isnt good enough. Next 4 weeks should bring some clarity hopefully.

<< Previous

Bullboard Posts

Next >>

Exploration company provides project portfolio update